sciencelife.uchospitals.edu
Building Better Drugs, in Five Steps or Less
When the drug ezetimibe was approved in 2002, it was hailed by its makers as a new tool for lowering cholesterol and fighting heart disease in patients. In clinical trials, the drug (marketed by Me…